Vaccine and Infectious Disease Division
The Vaccine and Infectious Disease Division (VIDD) is a diverse and active community of scientists that operates under a model of strong faculty governance. VIDD’s Leadership oversees the routine functions of the Division in consultation with other standing committee.
M. Juliana McElrath, M.D., Ph.D.
Senior Vice President, Fred Hutch
Within VIDD, Dr. McElrath serves as PI and Director of the Laboratory Program for the HIV Vaccine Trials Network (HVTN). This international HIV vaccine laboratory program conducts translational immunological research in humans in a multicenter setting. While mentoring junior faculty, young investigators, and graduate students in their career paths, Dr. McElrath has also assumed a leadership role or been a major contributor in a number of integrated programs at the national and international level to advance a coordinated effort to tackle the HIV epidemic through prevention efforts: the Bill & Melinda Gates Foundation Innate Immunity Consortium (PI), the Microbicide Trials Network (Director, Immunology Core) and the Global HIV Vaccine Enterprise (Laboratory Working Group).
Dr. McElrath's laboratory seeks to identify the components of immunity that are important in preventing and controlling HIV-1 infection, with studies encompassing a broad range of translational research investigations in persons who experience unusual control of HIV-1. The McElrath Lab’s research is focused on obtaining a better understanding of the role HIV-1-specfic memory T cells play in protecting against mucosal HIV-1 transmission and determining optimal strategies to accomplish protection by vaccination.
Steve Self, Ph.D.
Associate Director, VIDD
Dr. Steve Self serves as Executive Director of the Statistical Center for HIV/AIDS Research & Prevention (SCHARP) within VIDD. He is Co-Program Head of Biostatistics and Biomathematics in the Public Health Sciences Division at the Hutch, and Professor of Biostatistics at the University of Washington. He has played an integral role in the scientific leadership and development of the HVTN since its inception. Dr. Self's research interests focus on the design, conduct and analysis of HIV prevention trials, with a particular emphasis on HIV vaccines and on the development of novel statistical methods.
He currently serves on a variety of scientific advisory boards and review panels, including the Board of Scientific Counselors for the U.S. National Cancer Institute, U.S. FDA Vaccine and Related Biological Products Advisory Committee, Scientific Advisory Board for the HIV Vaccine Development Program at St. Jude Children's Hospital, and Chair of the Data and Safety Monitoring Board for the National Cancer Institute HPV Vaccine Efficacy Trial.
Curt Malloy, JD, MPH
Malloy oversees all fiscal, budget, human resources, space and shared resource planning and operations.